1. Home
  2. MDGL vs NXT Comparison

MDGL vs NXT Comparison

Compare MDGL & NXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • NXT
  • Stock Information
  • Founded
  • MDGL 2011
  • NXT 2013
  • Country
  • MDGL United States
  • NXT United States
  • Employees
  • MDGL N/A
  • NXT N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • NXT Semiconductors
  • Sector
  • MDGL Health Care
  • NXT Technology
  • Exchange
  • MDGL Nasdaq
  • NXT Nasdaq
  • Market Cap
  • MDGL 6.8B
  • NXT 6.5B
  • IPO Year
  • MDGL N/A
  • NXT 2023
  • Fundamental
  • Price
  • MDGL $273.46
  • NXT $57.85
  • Analyst Decision
  • MDGL Strong Buy
  • NXT Buy
  • Analyst Count
  • MDGL 10
  • NXT 19
  • Target Price
  • MDGL $420.63
  • NXT $58.95
  • AVG Volume (30 Days)
  • MDGL 361.7K
  • NXT 2.7M
  • Earning Date
  • MDGL 05-01-2025
  • NXT 05-14-2025
  • Dividend Yield
  • MDGL N/A
  • NXT N/A
  • EPS Growth
  • MDGL N/A
  • NXT 3.00
  • EPS
  • MDGL N/A
  • NXT 3.47
  • Revenue
  • MDGL $317,383,000.00
  • NXT $2,959,197,000.00
  • Revenue This Year
  • MDGL $264.55
  • NXT $9.86
  • Revenue Next Year
  • MDGL $67.21
  • NXT $9.14
  • P/E Ratio
  • MDGL N/A
  • NXT $17.11
  • Revenue Growth
  • MDGL N/A
  • NXT 18.38
  • 52 Week Low
  • MDGL $200.08
  • NXT $30.93
  • 52 Week High
  • MDGL $377.46
  • NXT $62.31
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 40.03
  • NXT 71.77
  • Support Level
  • MDGL $281.76
  • NXT $56.55
  • Resistance Level
  • MDGL $295.60
  • NXT $60.19
  • Average True Range (ATR)
  • MDGL 12.78
  • NXT 2.66
  • MACD
  • MDGL -0.97
  • NXT 1.39
  • Stochastic Oscillator
  • MDGL 14.82
  • NXT 78.35

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About NXT Nextracker Inc.

Nextracker (and its subsidiaries) is a leading provider of intelligent, integrated solar tracker and software solutions used in utility-scale and distributed generation solar projects around the world. Nextracker's products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance. Nextracker has operations in the United States, Mexico, Spain and other countries in Europe, India, Australia, the Middle East, Africa, and Brazil.

Share on Social Networks: